(0.24%) 5 473.82 points
(0.24%) 39 211 points
(0.68%) 17 853 points
(1.70%) $82.93
(-4.08%) $2.50
(-0.06%) $2 338.30
(0.24%) $29.63
(-2.58%) $987.90
(-0.15%) $0.932
(-0.14%) $10.66
(-0.01%) $0.791
(1.05%) $86.63
0.15% $ 20.00
Live Chart Being Loaded With Signals
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 387 776 |
Volumen promedio | 677 842 |
Capitalización de mercado | 843.96M |
EPS | $-0.200 ( Q2 | 2023-02-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-20.83 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.103 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Paulsen Erik | Sell | 20 627 | Restricted Stock Units |
2023-04-27 | Paulsen Erik | Sell | 700 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 138 957 | Common Stock |
2023-04-27 | Points Jeffrey S. | Sell | 34 051 | Common Stock |
2023-04-27 | Rempe Stephen J. | Sell | 75 659 | Common Stock |
INSIDER POWER |
---|
-86.84 |
Last 100 transactions |
Buy: 675 433 | Sell: 1 911 221 |
Volumen Correlación
Cardiovascular Systems Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cardiovascular Systems Correlación - Moneda/Commodity
Cardiovascular Systems Finanzas
Annual | 2022 |
Ingresos: | $236.22M |
Beneficio Bruto: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2022 |
Ingresos: | $236.22M |
Beneficio Bruto: | $172.78M (73.14 %) |
EPS: | $-0.940 |
FY | 2021 |
Ingresos: | $258.97M |
Beneficio Bruto: | $197.84M (76.39 %) |
EPS: | $-0.350 |
FY | 2020 |
Ingresos: | $236.55M |
Beneficio Bruto: | $187.79M (79.39 %) |
EPS: | $-0.790 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cardiovascular Systems
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico